Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model
- 1 May 2001
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (5) , 371-377
- https://doi.org/10.1038/sj.cgt.7700314
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 18 references indexed in Scilit:
- Human Inflammatory Cells Within the Tumor Microenvironment of Lung Tumor Xenografts Mediate Tumor Growth Suppression in Situ that Depends on and Is Augmented by Interleukin-12Journal of Immunotherapy, 2001
- Cytokines Delivered by Biodegradable Microspheres Promote Effective Suppression of Human Tumors by Human Peripheral Blood Lymphocytes in the SCID–Winn ModelJournal of Immunotherapy, 2000
- A Universal Granulocyte-Macrophage Colony-Stimulating Factor-Producing Bystander Cell Line for Use in the Formulation of Autologous Tumor Cell-Based VaccinesHuman Gene Therapy, 1999
- Enhanced Tumor Protection by Granulocyte-Macrophage Colony-Stimulating Factor Expression at the Site of an Allogeneic VaccineHuman Gene Therapy, 1998
- Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I studyGene Therapy, 1998
- A comparison of efficacy and specificity of three NK depleting antibodiesJournal of Immunological Methods, 1996
- Cancer vaccines: the interleukin 2 dosage effect.Proceedings of the National Academy of Sciences, 1995
- Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice.The Journal of Experimental Medicine, 1993
- Human‐mouse lymphoid chimeras: host‐vs.‐graft and graft‐vs.‐host reactionsEuropean Journal of Immunology, 1992
- Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.The Journal of Experimental Medicine, 1992